RLAY — Relay Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1812364 ·
Last close
$16.47
Market Cap
$3.64B
52W High
$21.27
52W Low
$6.25
ADV30
2,540,519
Next earnings
2026-11-04

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -90,245,000 -81,745,000 901,692,000 124,184,000 82,696,000
Jun 2026 350,000 — -90,824,000 -83,707,000 967,457,000 121,189,000 77,448,000
Mar 2026 3,000,000 — -78,590,000 -73,291,000 699,613,000 204,589,000 57,430,000
Dec 2025 7,000,000 — -60,630,000 -54,890,000 621,331,000 84,018,000 54,271,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-214,020,000
Investing CF
$-222,292,000
Financing CF
$467,871,000
CapEx
$-411,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.51
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-2,253,512,000
Inventory
—
Receivables
—
ST Investments
$724,458,000
EBIT TTM
$-320,289,000
Pretax Income TTM
$-293,633,000
Interest Exp TTM
—
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$10,350,000
EBITDA
$-318,545,984
Free Cash Flow
$-117,454,624
Enterprise Value
$3,288,234,240
Total Cash
$848,641,984
Total Debt
$27,030,000
Shares Out
220,959,470
Trailing EPS
$-1.50
Book Value
$3.73
ROE
-41.2%
ROA
-25.5%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 15,355,000 -302,738,000 -276,479,000 621,331,000 54,271,000 567,060,000 -235,455,000
Dec 2024 10,007,000 -385,674,000 -337,708,000 871,296,000 93,504,000 777,792,000 -249,107,000
Dec 2023 25,546,000 -379,422,000 -341,973,000 843,980,000 91,977,000 752,003,000 -300,316,000
Dec 2022 1,381,000 -310,952,000 -290,509,000 1,099,771,000 149,553,000 950,218,000 -229,490,000

TTM Snapshot

Revenues TTM
$10,349,000
NetIncome TTM
$-286,037,000
OpCashFlow TTM
—
Assets (Latest)
$967,457,000
Forward EPS
$-1.60

Max Pain — expiry 2026-12-18

max pain strike: $19.00 · spot: $16.51 · call oi: 8,870 · put oi: 7,423
Expected Move to 2026-12-18: ±$4.58 (27.71%) — implied range $11.94 – $21.09 · ATM straddle on $17.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
IOVA IOVANCE BIOTHERAPEUTICS, INC. $3.48B $7.53 —
TARS Tarsus Pharmaceuticals, Inc. $3.86B $78.20 —
CRSP CRISPR Therapeutics AG $3.89B $40.15 —
ADMA ADMA BIOLOGICS, INC. $3.02B $13.63 —
VCEL Vericel Corp $2.95B $57.88 —

News headlines (Yahoo Finance, 1h cache)

Relay Therapeutics (RLAY) Could Be 26% Undervalued After Third Quarter 2026 Results
2026-11-10 01:16 · Yahoo
Relay Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Updates
2026-11-04 21:05 · Yahoo
Relay Therapeutics to Participate in Three Upcoming Investor Conferences in November
2026-11-02 21:05 · Yahoo
Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026
2026-10-28 20:12 · Yahoo
Relay Therapeutics (RLAY) Stock Looks Fully Priced On Book Value
2026-10-08 06:12 · Yahoo
Is Relay Therapeutics (RLAY) Cheap After Its Pullback Or Is The Upside Priced In?
2026-10-08 02:10 · Yahoo
X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics
2026-09-22 13:30 · Yahoo
Relay Therapeutics CFO Sells 17,717 Shares for $350,000
2026-09-02 17:20 · Yahoo
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
2026-09-01 20:46 · Yahoo
This 'Dynamo' Biotech Puts AI-Fueled Breakout In Motion
2026-08-21 19:43 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.